Month: September 2024

Selskabet annoncerede i selskabsmeddelelse 13/2024, at man havde indledt en proces med at gennemføre et identitetsskifte med Nasdaq for fortsat at kunne bevare sin status som børsnoteret selskab. Nasdaq har dags dato meddelt selskabet, at man har modtaget en betinget godkendelse herom, men at den fortsatte børsnotering er betinget af, at man opdaterer selskabets risikobeskrivelse iht. selskabets fremadrettede formål, hvor man udover strategiske partnerskaber indenfor biotek også ønsker at kunne danne partnerskaber i andre brancher samt investere i kapitalandele og ejendomme. Selskabet vil derfor fortsætte processen med Nasdaq ift. at opdatere denne risikobeskrivelse i henhold til Prospektforordningens artikel 16, og såfremt at Nasdaq efterfølgende godkender denne beskrivelse, så vil selskabet i forlængelse heraf indkalde til en ekstraordinær...

The 2025 B4 buyers can qualify for more than $100,000 in state and federal incentives on all-new, all-electric Class 4 truck BREA, Calif., Sept. 18, 2024 (GLOBE NEWSWIRE) — via IBN – Mullen Automotive, Inc. (NASDAQ: MULN) (“Mullen” or the “Company”), an electric vehicle (“EV”) manufacturer, announces today that its subsidiary, Bollinger Motors (“Bollinger”), has released pricing for the 2025 Bollinger B4 Chassis Cab with a Manufacturers Suggested Retail Price (“MSRP”)  of $158,758. The Bollinger B4 Chassis Cab is an all-new, all-electric Class 4 commercial truck designed from the ground up with extensive fleet and upfitter input. Bollinger’s unique chassis design protects the 158-kwh battery pack and components to offer impressive capability and safety in the commercial market. The company commenced serial production of the B4...

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM THE UNITED STATES, CANADA, AUSTRALIA, JAPAN, THE REPUBLIC OF SOUTH AFRICA OR ANY OTHER JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. HARGREAVE HALE AIM VCT PLC LEI: 213800LRYA19A69SIT31 18 September 2024 Intention to launch an offer for subscription The Board of Hargreave Hale AIM VCT plc (the “Company”) is pleased to announce its intention to launch an offer for subscription of new ordinary shares (the “Offer”) in relation to the 2024/2025 and 2025/2026 tax years. Full details of the Offer will be set out in a prospectus to be published by the Company in connection with the Offer in the coming months. A further announcement will be made upon the Offer’s launch. For...

Advanced recycling technology enables recycled plastic to transform into new cracker packaging* EAST HANOVER, N.J., Sept. 18, 2024 (GLOBE NEWSWIRE) — Mondelēz International has announced today that it will source plastic linked to advanced recycling technology (also known as chemical or molecular recycling) for the production of packaging across the majority of SKUs for its Triscuit Crackers in the U.S. and Canada. Triscuit is an iconic snacking brand with a history and heritage dating back more than a century. Through this initiative, the Triscuit brand is contributing to the sourcing of recycled plastics via the ISCC mass balance approach, helping to support a more circular pack economy in the U.S. and Canada. This contributes to Mondelēz International’s goal of achieving about 5% recycled plastic content by 2025**. In the past,...

SON-1010 is a targeted immune activation cancer therapy designed to turn ‘cold’ tumors ‘hot’ Topline safety data of SB101 Phase 1 study expected by Q4 2024 PRINCETON, NJ, Sept. 18, 2024 (GLOBE NEWSWIRE) — Sonnet BioTherapeutics Holdings, Inc. (the “Company” or “Sonnet”) (NASDAQ: SONN), a clinical-stage company developing targeted immunotherapeutic drugs, today announced the completion of enrollment and initiation of dosing in its Phase 1 SB101 clinical trial of SON-1010 (IL12-FHAB) in adult patients with advanced solid tumors. The Company expects to report topline data from this study in Q4 2024. Pankaj Mohan, Founder and Chief Executive Officer of Sonnet commented, “This milestone is an important step forward in our development program for SON-1010 as a monotherapy. We are encouraged by the data seen to date demonstrating safety...

Leading medical clinics become key regional resources to offer FemaSeed infertility treatment ATLANTA, Sept. 18, 2024 (GLOBE NEWSWIRE) — Femasys, Inc., (Nasdaq: FEMY), a leading biomedical company focused on addressing significant unmet needs of women worldwide with a broad portfolio of in-office, accessible, and innovative therapeutic and diagnostic products, announces the onboarding of the first infertility medical clinic customers to offer its FemaSeed infertility treatment to patients in California and Florida. “Femasys has begun partnering with infertility centers across the United States, enabling them to offer FemaSeed to their patients. We are excited to welcome Reproductive Fertility Center and Palm Beach Fertility Center as our first customers,” said Femasys CEO Kathy Lee-Sepsick. “We are enthusiastic about expanding...

Del Taco continues Florida expansion with first location in Charlotte County, marking the leading Mexican QSR chain’s 12th location in the state PORT CHARLOTTE, Fla., Sept. 18, 2024 (GLOBE NEWSWIRE) — Del Taco, the nation’s second-largest Mexican quick service restaurant,* announced the opening of the newest location at 19001 Murdock Circle, Port Charlotte, Florida. This is the brand’s first location in Port Charlotte and the third location for the franchisees that brought Del Taco’s bold flavors and sleek design to Bradenton. Featuring Del Taco’s sleek, contemporary Fresh Flex layout, the Port Charlotte restaurant invites customers to “Go Bold” with a fresh, vibrant interior design, and its open-layout kitchen brings to life the brand’s commitment to freshness. For orders on the go, Del Taco guests can breeze through the drive-thru...